Enlivex Therapeutics Current Assets

Enlivex Therapeutics (ENLV) currently reports a current assets of $1.7B as of December 2025. That compares with $26M in the prior-year period — up 6606.3% year over year. Use the charts on this page to explore Enlivex Therapeutics's current assets history and peer comparisons.

Enlivex Therapeutics's current assets increased from $26M to $1.7B — a 6606.3% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enlivex Therapeutics reported $1.7B in current assets as of December 2025. That compares with $26M in the prior-year period — up 6606.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $1.7B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Enlivex Therapeutics, and consider following ENLV for alerts when major investors trade the stock.

Enlivex Therapeutics is classified in the Healthcare sector. On current assets, it currently shows $1.7B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ENLV with unrelated industries.